The Sun Pharma stock rallied 3% today after the drug-maker offered to acquire 100% in the Israeli drug-firm Taro Pharma in which it has 66% stake. While the move got a thumbs-up from analysts, some of Taro’s large shareholders may play spoilsport, reports CNBC-TV18's Archana Shukla.
first published: Oct 19, 2011 10:11 pm
A collection of the most-viewed Moneycontrol videos.
You are already a Moneycontrol Pro user.
